Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Myocardial Infarction Secondary to Marijuana-Induced Coronary Vasospasm

Krunal H. Patel, Pramod Theetha Kariyanna, Apoorva Jayarangaiah, Nabila Khondakar, Madina Abduraimova, Samy I. McFarlane*

Department of Internal Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY, USA – 11203

Abstract: With the rise of the number of states fully legalizing marijuana, the use of this substance in the United States is at an all-time high. This increasing legalization gives the impression that marijuana is rather safe. However, multiple reports by our groups and others documented serious cardiovascular complications associated with marijuana use ranging from life threatening arrhythmia to myocarditis and myocardial infarction. In this report, we present a case of a 61 year old man presented with left sided typical chest pain shortly after marijuana consumption with the diagnosis of non ST-elevation myocardial infarction (NSTEMI) established based on clinical, EKG and troponin values with eventual cardiac catheterization documenting non-occlusive coronary artery disease with 30% obstruction of the proximal first obtuse marginal artery. We also review the putative pathophysiologic mechanisms of marijuana induced coronary vasospasms, highlighting the implications of these findings in the evaluation and management of cardiac chest pain in marijuana users.

Keywords: marijuana, cannabis, myocardial infarction, vasospasm

Received November 15, 2019; Revised December 21, 2019; Accepted January 18, 2020

Citation: Krunal H. Patel, Pramod Theetha Kariyanna, Apoorva Jayarangaiah, Nabila Khondakar, Madina Abduraimova, Samy I. McFarlane, Myocardial Infarction Secondary to Marijuana-Induced Coronary Vasospasm. American Journal of Medical Case Reports, 8 (3). 79-82. January 2020. doi:10.12691/ajmcr-8-3-4

1. Introduction

With the recent increase in legalization of recreational and medical marijuana across the United States over the past decade, clinicians have seen a dramatic rise in marijuana related hospitalizations. With Colorado being the first state to legalize recreational marijuana (cannabis) it has become the center of a nationwide study demonstrating the effects increased marijuana consumption has on hospitalizations. A recent 2016 study conducted by Colorado Health Department, showed that since the passing of recreational marijuana use there has been a staggering increase in hospitalizations secondary to marijuana use (Figure 1) [1]. We present a case of non-ST segment myocardial infarction secondary to marijuana induced coronary vasospasm (prinzmetal angina) in an elderly male who presented with chest pain after recreational marijuana use.

Endocannabinoids have multiple effects on various organs/organ systems primarily though transmembrane receptors that are G-protein coupled- CB1 and CB2. CB1 is known for its inflammatory role, and conversely CB2 having anti-inflammatory properties [2,3,4]. It has been shown through molecular biological analysis via western blot and flow cytometry that CB1 receptors are expressed within the endothelium [4]. CB1 receptors activation within the coronary endothelium amplifies the reactive oxygen species-mitogen-activated protein kinases (ROS-MAPK) activation cell death pathway leading to excessive inflammation and oxidative stress formation causing endothelial dysfunction [3,4]. ROS can trigger vasoconstrictor stimulus, in addition to the direct G-protein and ion channel dysregulation with CB1 activation which both combined leads to smooth muscle cell hyper reactivity within coronary vessels [2,3,4].

2. Case Report

A 61-year-old man with a history of vasospastic angina, hyperlipidemia, asthma, and implantable cardioverter-defibrillator as he had survived ventricular tachycardia (secondary prevention), presented with sharp substernal chest pain that radiated down the left arm, 10/10 in intensity. He also complained of associated nausea, and had experienced a one-time episode of non-bloody, non-bilious vomiting, along with diaphoresis. At presentation his pulse was 89 beats per minute and blood pressure was 148/72 mm Hg. Electrocardiogram (EKG) showed tall hyper acute T-waves in the precordial leads V2-V4 (Figure 1). Chest x-ray was negative for any intrapulmonary pathologies, and BNP was 73 pg/ml. Initial troponin was 0.17 mg/dl, which trended up to 0.19, 0.40 and peaked at 0.69 mg/dl. Of note, the patient had initially denied taking any illicit drugs, it was not until later that the patient stated that it was his birthday and he had smoked marijuana earlier that day and shortly before experiencing chest pain. Upon evaluation in the emergency department, he stated that his symptoms began to slightly improve with one-time sublingual nitroglycerin. A diagnosis of non ST-segment myocardial infarction was established (NSTEMI) and aspirin 325 mg, clopidegrol 300 mg and heparin drip were initiated as a part of NSTEMI management protocol. Patient underwent urgent coronary angiogram which revealed minimal coronary irregularities suggestive of non-obstructive CAD and 30% obstruction of the proximal first obtuse marginal artery was noted (Image 1 and Image 2). When compared with his angiogram from another hospital of 2018, there were no changes in the coronaries. No acute occlusions, stenosis, or changes were noted when compared to the patients’ previous angiogram from the previous year. Upon through review of reports his previous hospitalization at other facilities it became apparent that patient had similar presentations with chest pain after smoking marijuana and was managed medically for NSTEMI and coronary angiogram had not shown any flow limiting stenosis. Patient was educated on stopping smoking in general, but specifically refraining from marijuana use to which he agreed. Patient was discharged on dual antiplatelet therapy, calcium channel blocker diltiazem and high intensity statins. Beta-blockers were not prescribed as patients

3. Discussion

Our diagnosis of vasospastic angina was made based on the Coronary Vasomotion Disoders International Study group (COVADIS) criteria [5]. The criteria states that there should be nitrate responsive angina with an associated transient EKG changes. Angiographic evidence of coronary evidence of coronary artery spasm is not required but can be replaced with EKG findings. A provocation test of coronary spasm and subsequent response with nitrates and/or CCB was not done in this patient. With the temporal association of his marijuana use and subsequent vasospastic angina pain, marijuana was suspected to be the primary trigger in his case.

Figure 1. EKG showing tall hyper acute T-waves in the precordial leads V2-V4. NSR

Image 1. Right coronary artery angiogram in left anterior oblique caudal view showing mild luminal irregularities and no obstructive lesion.

Image 2. Left coronary artery angiogram in right anterior oblique caudal view showing mild luminal irregularities and no obstructive lesion

Figure 2. Proposed Pathogenetic mechanisms of Endothelial Damage associated with cannabis use

There are numerous pathophysiology mechanisms by which marijuana can cause myocardial infarction [6]. The endothelium plays an important role in the regulation of the coronary vascular tone [7,8,9]. This is primarily done with the help of several vasodilators, the most important of which is nitric oxide (NO) released by coronary endothelial cells [8]. Hence, endothelial damage can impair vasodilation, favoring coronary artery spasms (CAS) in response to a vasoconstrictor stimulus (Figure 2) [4,7]. It is known that marijuana activates CB1 receptors within the endothelium and there is a ROS-MAPK activation cascade [4]. This results in the generation of multiple ROS, which is a vasoconstrictive stimulus leading to smooth muscle constriction within coronary vessels [6]. Of note, not only are ROS a vasoactive stimulus but they also promote endothelial damage, starting the pathogenesis in the first place [4,6] Multiple cases of coronary slow and no flow phenomenon has been reported [10,11,12]. Coronary Slow Flow Phenomenon (CSFP) is an angiographic finding, where by there is a delay in distal vessel opacification in the absence of a significant occlusion and/or stenosis of the coronary vessel [13]. This underlying innocuous finding has great clinical implications since it has been linked to various effects such as myocardial ischemia, recurrent ACS, arrhythmias, and even sudden cardiac death [14,15,16,17,18]. In addition, CSFP and vasospastic angina share common features, such as both improve symptomatically from chest pain following oral calcium channel blockers (CCB) an oral nitroglycerin [15]. Individuals who were observed with CSFP and had endomyocardial biopsies were observed to have fibromuscular hyperplasia, endothelial degradation, reduction in lumen size, and abnormalities of the mitochondria, and glycogen content [6]. It is likely based on these findings that CSFP is multifactorial, altering the endothelium on a biochemistry level. Coronary angiograms in these patients with CSFP are classically referred to as “negative and normal,” or to have “minimal non-obstructive disease,” which leads to patients being referred to as negative cardiac catheterization myocardial infarctions [19,20]. These findings correlate with what was seen objectively within our case report. There are documented cases which associate CSFP with marijuana use, in addition there have been correlation of CSFP and runs of ventricular tachycardia as well [19]. Finally, when marijuana induced myocardial infarction is secondary to vasospasm the appropriate management would be abstinence to marijuana, dual antiplatelets, high intensity statins and calcium channel blockers as well as nitrates [21].

4. Conclusion

In this report, we presented a unique case of myocardial infarction, induced by coronary vasospasm associated with marijuana use. While cardiovascular complications associated with marijuana use are published by multiple authors, including several papers from our group, vasospastic coronary angina, that is commonly reported with cocaine abuse, has not been sufficiently emphasized in the literature. This fact in and of itself gives our current case report the novelty as well as the impotence to highlight this critical association between coronary vasospasm and marijuana that is currently the most commonly abused recreational drug in the USA.

Acknowledgements

This work is supported, in part, by the efforts of Dr. Moro O. Salifu M.D., M.P.H., M.B.A., M.A.C.P., Professor and Chairman of Medicine through NIH Grant number S21MD012474.

References

[1]   | Hall K, Vigil D, Contreras E, Barker L, Berg K, Bol K, Dyke M. Monitoring Possible Marijuana Related Health Effects in Colorado. Colorado Hospital Association (CHA). 2016.
[2]   | Matsuda LA, Lolait SJ, Brownstein MJ, Young CA, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature (Lond). 1990; 346: 561.
[3]   | Munro S, Thomas KL, Abu-Shaar M. Molecuar characterization of peripheral receptor for cannabinoids. Nature (Lond). 1993: 365: 61-65.

[4]  
Rajesh, M., Mukhopadhyay, P., Haskó, G., Liaudet, L., Mackie, K. and Pacher, P. (2010), Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. British Journal of Pharmacology, 160: 688-700

[5]   | Beltrame JF, Crea F, Kaski JC, et al. International standardization of diagnostic criteria for vasospastic angina. Eur Heart J 2017; 38(33):2565-2568, by permission of Oxford University Press on behalf of the European Society of Cardiology.
[6]   | Kattoor A, Mehta J. Marijuana and Coronary Artery Disease. American College of Cardiology. Sep 22 2016.
[7]   | Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288:373-376.
[8]   | Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation. 1989; 80: 1-9.
[9]   | Lanza G, Careri G, Crea F. Mechanisms of Coronary Artery Spasm. Circulation. 2011;124:1774-1782.
[10]   | Wengrofsky, P., Mubarak, G., Shim, A., Kariyanna, P.T., Buzidkowski, A., Schwartz, J., McFarlane, S.I. Recurrent STEMI Precipitated by Marijuana Use: Case Report and Literature Review. AM J Med Case Report. 2018 Oct 5th. PMCID: PMC6173205.
[11]   | Gunawardena, V.M., Rajapakse, S., Hearth, J., Amarasena, N., Myocardial Infarction Following Cannabis Induced Coronary Vasospasm. BMJ Case Reports. 2014. Nov 12th. PMCID: PMC4244407.
[12]   | Rezkalla, S.H., Sharma, P., Kloner, R.A. Coronary No-Flow and Ventricular Tachycardia Associated with Habitual Marijuana Use. Annals of Emergency Medicine. (2003).
[13]   | Horjeti B, Goda A. Acute ischemia manifestation in a patient with coronary slow flow phenomenon. J Electrocardiol 2012; 45: 277-9.
[14]   | Cutri N, Zeitz C, Kucia AM, et al. ST/T wave changes during acute coronary syndrome presentation in patients with the coronary slow flow phenomenon. Int J Cardiol 2011; 146: 457-8.
[15]   | Wozakowska-Kapłon B, Niedziela J, Krzyzak P, et al. Clinical manifestations of slow coronary flow from acute coronary syndrome to serious arrhythmias. Cardiol J 2009; 16: 462-8.
[16]   | Saya S, Hennebry TA, Lozano P, et al. Coronary slow flow phenomenon and risk for sudden cardiac death due to ventricular arrhythmias: a case report and review of literature. Clinal Cardiology 2008; 31: 352-5.
[17]   | Michael M, Breall J. No-Reflow Phenomenon During PCI. Cardiology. July 15th 2011.
[18]   | Kariyanna P.T., Wengrofsky P, Jayarangaiah A, Haseeb S, Salciccioli L, et al. (2019) Marijuana and Cardiac Arrhythmias: A Scoping Study. Int J Clin Res Trials 4: 132.
[19]   | Khouzam R, Kabra R, Soufi M. Marijuana, bigeminal premature ventricular contractions and sluggish coronary flow: Are they related? Journal of Cardiology Cases 8. 2013. June 28th. issues 121-124.
[20]   | Alvarez C, Siu H. Coronary Slow-Flow Phenomenon as an Under recognized and Treatable Source of Chest Pain: Case Series and Literature Review. J iNvestig Med High Impact Case Rep. 2018 Jul 17th.

[21]  
Amsterdam, E.A, Wenger, N.K., Brindis, R.G, CaseyJr, D.E, Ganiats, T.G, HolmesJr, D.R, Jaffe, A.S, Jneid, Hani, Kelly, R.F., Kontos, M.C, Levine, G.N, Liebson, P.R., Mukherjee, D., Peterson, E.D., Sabatine, M.S., Smalling, R.W., Zieman, S.J. (2014) AHA/ACC Guideline for the Management of Patients With Non-ST Elevation Acute Coronary Syndromes. Circulation. 2014. 130:e344-e426.